Tucson

25–48 of 715 companies

• 

  AgentSage

  Real estate

  Early stage

• 

  Aging Health Sciences, Inc.

  Health

  Aging Health Sciences, Inc. is a nutraceutical company that provides nutritional products based on scientific research to support long-term health. The company's main product is MacularPM, a supplement for eye health designed to maintain healthy vision with age. It is targeted toward individuals looking for nutritional support for aging eyes, especially those with a family history of vision problems or early signs of age-related changes.The formulation for MacularPM was created by vision scientists with input from academic researchers. The supplement contains ingredients studied for their role in retinal health, such as L-DOPA, melatonin, and antioxidants like Vitamins C and E, lutein, and zeaxanthin. The company's business model is direct-to-consumer, selling MacularPM through its website with both single purchase and subscription options available. Aging Health Sciences aims to connect academic research with accessible wellness solutions, focusing on formulations that are based on scientific findings. Research has indicated that supplementation with L-DOPA may help reduce the progression from dry Age-Related Macular Degeneration (AMD) to the more severe wet AMD. Additionally, studies have shown that melatonin can protect retinal cells from oxidative damage, a contributing factor to AMD.

  Early stage · 2–10 employees

• 

  Air2N

  Food

  Air2N has developed a pioneering nitrogen-fixing technology that generates nitrogen nutrients for agriculture directly within the soil. Banister developed a method to extract nitrogen from the atmosphere, producing nitrates, nitrites, and ammonia in-situ, which enhances the soil's natural nitrogen cycle and negates the need for topical nitrogen chemical applications. The core of Air2N's offering is a material that, once installed in the soil, creates long-lasting nitrogen nutrients without requiring any energy input, relying solely on water. A key feature of this technology is its contribution to water conservation, as it has been shown to reduce irrigation water needs by up to 50%. The material achieves this by reducing evaporation around the plant and expanding when wet and contracting as it dries. This cyclical process also provides the benefit of automated soil aeration, exposing more of the material and soil to the air. The company's products have undergone eight years of lab and in-ground testing, ensuring a performance lifetime of over 10 years. Air2N's business model centers on providing solutions for regenerative agriculture and climate technology. For every ton of nitrogen replaced, the technology eliminates two tons of CO2 emissions typically associated with the industrial Haber-Bosch process. The company serves farmers and gardeners, aiming to solve major agricultural challenges like nitrogen water pollution from runoff and irrigation water scarcity. As of late 2025, the company remains unfunded.

  Early stage

• 

  Airth

  Early stage · 2–10 employees

• A

  Airtronics

  Early stage · $170K raised

• 

  Airy Optics

  Semiconductors

  Early stage · 2–10 employees

• 

  Aladdin Graphics on Apparel

  Home & living

  Early stage · 1 employees

• 

  AlgaeCell

  Early stage · 2–10 employees

• 

  ALIO IT

  Alio IT is a software development and IT consulting firm characterized by its agile decision-making processes and leadership by senior developers. The company focuses on delivering projects on budget and on schedule, leveraging deep knowledge in software development and project management. Alio IT serves a diverse range of clients, providing tailored solutions that meet specific business needs. Operating in the competitive IT services market, the company distinguishes itself by its ability to adapt quickly to client requirements and market changes. The business model revolves around offering consulting services and custom software solutions, generating revenue through project-based engagements and long-term client relationships. Alio IT's approach ensures efficient project delivery, making it a reliable partner for businesses seeking robust IT solutions.

  Early stage · 11–50 employees

• 

  ALL ON IT LLC

  Health

  Early stage

• 

  Alliance Financial Resources LLC

  Fintech

  Alliance Financial Resources LLC was a mortgage and financial services company that is no longer in business. E5 Home Loans is the business name for Capp Mortgage, L.L.C. and is based in Phoenix, Arizona. The firm's business model is centered on offering a variety of loan programs to fit different client scenarios, whether they are first-time homebuyers or experienced investors. Their product offerings include Fixed-Rate Mortgages, Adjustable-Rate Mortgages (ARMs), Conforming Loans, Jumbo & Super Jumbo Loans, and government-backed loans such as FHA, VA, and USDA loans, with terms ranging from 5 to 30 years. The process for clients involves completing a pre-approval request, receiving and comparing loan options, and then selecting the most suitable offer. The company states that it aims to provide competitive rates by maintaining lower margins. E5 Home Loans is licensed to operate in Arizona, Florida, New Mexico, and Maine.

  Early stage · 11–50 employees

• A

  allthebesthairproducts

  Early stage

• 

  America's Rehab Campuses

  Health, Real estate

  Early stage · 11–50 employees

• 

  American Advertising Federation Tucson

  Media

  Early stage · 2–10 employees

• 

  American Top Lift

  Early stage · 1 employees

• A

  American Turbo Systems

  Early stage

• 

  Ampcera

  Energy, Transportation

  Ampcera is a pioneering company specializing in the development and commercialization of high-performance solid state electrolyte (SSE) materials and scalable manufacturing technologies for next-generation lithium batteries. The company primarily serves clients in the electric vehicle (EV) industry and other sectors requiring advanced battery solutions. Ampcera operates in the rapidly growing market for solid state batteries (SSBs), which offer significant advantages over traditional liquid electrolyte batteries, including higher energy density, faster charging times, improved safety, and long-term stability.Ampcera's business model focuses on both the development of proprietary SSE materials and the commercialization of these materials through scalable manufacturing processes. The company generates revenue by selling its advanced SSE materials and licensing its manufacturing technologies to battery manufacturers and other stakeholders in the EV supply chain. Ampcera's innovative roll-to-roll manufacturing technology further enhances the scalability and cost-effectiveness of its solutions, making it a key player in the push towards more affordable and efficient electric vehicles.

  Breakout · 11–50 employees · $17.5M raised

• 

  Ampira

  Health

  Ampira delivers a comprehensive hearing care solution packaged as a "service in a box" designed for individuals who lack access to conventional audiology services. The company's offering combines a durable, rechargeable behind-the-ear hearing aid with guided software. This integrated system allows users to conduct at-home hearing assessments and receive an automatic initial fitting.A core feature of Ampira's model is its seamless connection to a network of licensed audiologists. This telehealth capability enables professionals to perform remote fine-tuning and provide ongoing follow-up care, ensuring a continuous and personalized rehabilitation process. By focusing on improving speech clarity in noisy environments, the technology aims to reduce listening fatigue and the social isolation often associated with hearing loss.Ampira's business model targets patients and their families in underserved regions globally. The company also partners with clinics, non-governmental organizations (NGOs), and public health systems that serve these low-access communities. By bundling the hardware, software, and telehealth services, Ampira aims to transition communities from having no hearing rehabilitation options to a scalable system of clear and continuous care.

  Early stage · 1 employees

• 

  Applied Energetics

  Energy

  Breakout · 11–50 employees · $2.1M raised

• 

  Aqualung Therapeutics

  Health

  Aqualung Therapeutics is a biotechnology company focused on developing innovative treatments for serious inflammatory disorders. The company's core product is a novel anti-inflammatory monoclonal antibody designed to target and mitigate severe inflammation. Aqualung Therapeutics operates in the biopharmaceutical market, primarily serving healthcare providers and patients affected by conditions such as COVID-19, prostate cancer, and radiation-induced lung injury. The business model revolves around research and development, clinical trials, and eventual commercialization of its proprietary biologic therapies. Revenue is generated through funding rounds, partnerships, and future sales of approved treatments. The company is currently seeking $15 million in Series A funding to advance the manufacturing of its lead drug candidate.

  Breakout · 2–10 employees · $18.0M raised

• A

  AQVac

  Health

  AQVac LLC is a biotechnology startup spun out of the University of Arizona in 2024, focused on addressing diseases in aquaculture. The company is commercializing a novel, orally-delivered viral vector platform designed to protect finfish and crustaceans from various pathogens. This technology aims to replace traditional injection-based vaccinations, offering a less stressful and more efficient method for disease prevention in farmed aquatic animals. Dr. Dhar is an expert in aquatic animal diseases, particularly in shrimp and other crustaceans. His research background is centered on the development of diagnostics, vaccines, and therapeutics for the aquaculture industry. The formation of AQVac was facilitated by Tech Launch Arizona, the university's commercialization arm, which helps bring faculty inventions to the marketplace. AQVac's primary product is a viral vector-based oral vaccine and therapeutic solution. By administering the vaccine orally, likely mixed with feed, aquaculture farms can treat entire populations at once, improving biosecurity and overall herd health. This approach is a significant development in a market where disease outbreaks can lead to substantial economic losses. The company operates in the growing aquaculture technology sector, which is increasingly vital for global food security as it provides a sustainable alternative to wild-capture fishing.

  Early stage

• 

  Araca

  Fintech

  Early stage · 11–50 employees · $850K raised

• A

  Arcadeinabox

  Gaming

  Early stage

• A

  Archangel Atomics

  Early stage